The IGF axis and hepatocarcinogenesis.

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• The insulin-like growth factor (IGF) axis plays a critical role in cellular growth and development.
• Deregulation of the IGF axis is implicated in various cancers, including hepatocellular carcinoma (HCC).

Purpose of the Study:

• To investigate the specific alterations within the IGF axis during HCC development.
• To identify key molecular events contributing to malignant transformation and tumor growth in HCC.

Main Methods:

• Analysis of IGF axis components, including IGFs, IGF binding proteins (IGFBPs), IGFBP proteases, and IGF receptors, in HCC and hepatoma cell lines.
• Assessment of gene and protein expression levels of IGF-II and IGF-I receptor (IGF-IR).
• Evaluation of IGFBP production, proteolytic degradation, and IGF-II/mannose 6-phosphate receptor (IGF-II/M6PR) function.

Main Results:

• Increased expression of IGF-II and the IGF-I receptor (IGF-IR) was observed in HCC and hepatoma cell lines.
• Alterations in IGFBP production and increased proteolytic degradation of IGFBPs were noted, leading to excess bioactive IGFs.
• Defective function of the IGF-II/mannose 6-phosphate receptor (IGF-II/M6PR) was identified.

Conclusions:

• The study highlights the critical role of IGF axis deregulation in HCC pathogenesis.
• Upregulation of IGF-II and IGF-IR, coupled with altered IGFBP metabolism and impaired IGF-II/M6PR function, significantly potentiates mitogenic effects driving HCC.
• Targeting the IGF axis presents a potential therapeutic strategy for HCC.